Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05446402 · ClinicalTrials.gov registry record · Phase 4
Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT05446402 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 29 participants.
The verdict
NCT05446402, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
The objective of this study is to compare tolerability of two similar commercially available over the counter acne regimens (Geologie and Proactiv) in individuals with mild to moderate acne vulgaris over a 12-week daily treatment course.
Interventions
- COMBINATION_PRODUCT Geologie Acne Regimen - one side of face
- COMBINATION_PRODUCT Proactive Acne Regimen - other side of face
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2023-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05446402
The ClinicalTrials.gov registry entry for NCT05446402 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Geologie Acne Regimen - one side of face is the first listed.
NCT05446402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05446402 about?
NCT05446402 is a clinical study titled "Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne". The objective of this study is to compare tolerability of two similar commercially available over the counter acne regimens (Geologie and Proactiv) in individuals with mild to moderate acne vulgaris over a 12-week daily treatment course.
What is the current status of trial NCT05446402?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2022-06-15. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05446402?
The interventions under investigation include: Geologie Acne Regimen - one side of face (COMBINATION_PRODUCT), Proactive Acne Regimen - other side of face (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05446402?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.